Learn from antibody–drug conjugates: consideration in the future construction of peptide-drug conjugates for cancer therapy
Abstract Cancer is one of the leading causes of death worldwide due to high heterogeneity. Although chemotherapy remains the mainstay of cancer therapy, non-selective toxicity and drug resistance of mono-chemotherapy incur broad criticisms. Subsequently, various combination strategies have been deve...
Збережено в:
| Автори: | , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
BMC
2022-11-01
|
| Серія: | Experimental Hematology & Oncology |
| Предмети: | |
| Онлайн доступ: | https://doi.org/10.1186/s40164-022-00347-1 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|